Table 1 Correlations between relapse rate and clinical variables.
Variables | Not relapse No. (%) | Relapse No. (%) | χ2 | P-value |
|---|---|---|---|---|
BM blast (n = 85) | 3.85 | 0.050 | ||
<5% | 36 (90.0) | 4 (10.0) | ||
≥5% | 33 (73.3) | 12 (26.7) | ||
WHO classification (n = 85) | 3.31 | 0.191 | ||
RCUD/RCMD/MDS-U | 34 (89.5) | 4 (10.5) | ||
RAEB-1 | 17 (77.3) | 5 (22.7) | ||
RAEB-2 | 18 (72.0) | 7 (28.0) | ||
IPSS (n = 84) | 2.73 | 0.098 | ||
Low/Int-1 | 41 (87.2) | 6 (12.8) | ||
Int-2/High | 27 (73.0) | 10 (27.0) | ||
Karyotype (n = 84) | 11.19 | 0.004 | ||
Good | 43 (91.5) | 4 (8.5) | — | |
Int | 17 (60.7) | 11 (39.3) | ||
Poor | 8 (88.9) | 1 (11.1) | ||
Secondary MDS (n = 85) | 1.01 | 0.449 | ||
Yes | 11 (91.7) | 1 (8.3) | ||
No | 58 (79.5) | 15 (20.5) | ||
Progression pre-HSCT(n = 85) | 8.02 | 0.005 | ||
Yes | 9 (56.2) | 7 (43.8) | ||
No | 60 (87.0) | 9 (13.0) | ||
Donor type (n = 85) | 0.07 | 0.932 | ||
MSD | 31 (81.6) | 7 (18.4) | ||
Non-MSD | 38 (80.9) | 9 (19.1) | ||
Conditioning (n = 85) | 0.47 | 0.491 | ||
MAC | 64 (82.1) | 14 (17.9) | ||
RIC | 5 (71.4) | 2 (28.6) | ||
ATG (n = 85) | 0.036 | 0.849 | ||
Yes | 32 (82.1) | 7 (17.9) | — | |
No | 37 (80.4) | 9 (19.6) | ||
Therapies pre-HSCT (n = 85) | 2.60 | 0.107 | ||
DAC ± chemotherapy | 32 (74.4) | 11 (25.6) | ||
BSC | 37 (88.1) | 5 (11.9) |
